We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · August 07, 2020

Efficacy and Safety of Alirocumab in Adults With Homozygous Familial Hypercholesterolemia

JACC: Journal of the American College of Cardiology

 

Additional Info

JACC: Journal of the American College of Cardiology
Efficacy and Safety of Alirocumab in Adults With Homozygous Familial Hypercholesterolemia: The ODYSSEY HoFH Trial
J Am Coll Cardiol 2020 Jul 14;76(2)131-142, DJ Blom, M Harada-Shiba, P Rubba, D Gaudet, JJP Kastelein, MJ Charng, R Pordy, S Donahue, S Ali, Y Dong, N Khilla, P Banerjee, M Baccara-Dinet, RS Rosenson

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading